BILL ANALYSIS

Senate Research Center	H.B. 1357
88R3877 JG-F	By: Holland (Huffman)
	Health & Human Services
	5/18/2023
	Engrossed

AUTHOR'S / SPONSOR'S STATEMENT OF INTENT

Currently, the state Medicaid program provides reimbursement for medication-assisted opioid or substance abuse treatment. However, there is a sunset provision for the section of state law requiring the Health and Human Services Commission to provide this reimbursement. Without any intervention from the legislature, reimbursement will cease on August 31, 2023.

H.B. 1357 seeks to remove this sunset date and make Medicaid reimbursement for medication-assisted treatment for opioid or certain substance use disorders permanent in state law.

H.B. 1357 amends current law relating to Medicaid reimbursement for certain medication-assisted treatments for opioid or substance use disorder.

RULEMAKING AUTHORITY

This bill does not expressly grant any additional rulemaking authority to a state officer, institution, or agency.

SECTION BY SECTION ANALYSIS

SECTION 1. Repealer: Section 32.03115(e) (relating to providing that Section 32.03115 (Reimbursement for Medication-Assisted Treatment for Opioid or Substance Use Disorder) expires August 31, 2023), Human Resources Code.

SECTION 2. Requires a state agency, if necessary for implementation of a provision of this Act, to request a waiver or authorization from a federal agency, and authorizes a delay of implementation until such a waiver or authorization is granted.

SECTION 3. Effective date: upon passage or September 1, 2023.